State guide · TN · prices checked Oct 3, 2026

GLP-1 in Tennessee: prices and Medicaid coverage

As of Oct 3, 2026, the cheapest GLP-1 program that ships to Tennessee is SnagRx at $69 a month, month to month, all in; 16 of the 21 partner programs we track ship there. Tennessee Medicaid covered GLP-1s for weight loss as of January 2026, one of 13 state programs that did, according to KFF.

Julian CaraulaniFounder, PriceTracker GLP-1Prices verified October 2026

Cheapest that ships to Tennessee

$69/mo

at SnagRx, month to month, all in.

Tennessee Medicaid, weight loss

Covered for weight loss

As of January 2026, per KFF. Diabetes: covered in every state.

$69/mo at SnagRx on SnagRx’s site ↗See all 16 that ship to Tennessee

On this page

Programs that ship to Tennessee
Does Tennessee Medicaid cover it?
Tennessee Medicaid in numbers
Medicare in every state
Neighbouring states
Common questions
Sources

Which GLP-1 programs ship to Tennessee?

16 of the 21 partner programs we track ship to Tennessee, from $69 a month, month to month at SnagRx to $299 at Willow, all in.

Cheapest first by what leaves your account each month, membership fees included, then the shorter plan. Each is a telehealth program: a clinician licensed in Tennessee reviews you online and a pharmacy mails the medication. Prices checked Oct 3, 2026.

Show all 16

Doesn’t ship to Tennessee · Enhance MD: each names Tennessee as a state it does not serve.

State list not verified · These say how many states they serve but not which, so we cannot say whether they ship here: bmiMD (48 states), DudeMeds (46 states), TMates (45 states), SkinnyRx (48 states).

Program links pay us a commission. The order is the all-in monthly price, never what anyone pays us. How we earn.

Cheapest GLP-1 nationally Cheapest semaglutide Cheapest tirzepatide Compare every state

Does Tennessee Medicaid cover GLP-1s for weight loss?

Covered for weight loss

Tennessee Medicaid covered GLP-1s for weight loss as of January 2026, one of 13 state programs that did, according to KFF.

Weight loss

Covered, January 2026

Type 2 diabetes

Required in every state

Heart risk, sleep apnea

Required (Wegovy, Zepbound)

Prior authorization

Typical when covered

Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. KFF counts coverage under fee-for-service; if your Tennessee Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.

What may have changed since January

CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Tennessee Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.

The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.

How many GLP-1s does Tennessee Medicaid pay for?

135,961 GLP-1 prescriptions in 2025, 20th of the 50 states and DC, with $142.7 million reimbursed before rebates.

Prescriptions, 2025

135,961

20th of 51

Medicaid paid

$142.7M

19th of 51, before rebates

Per prescription

$1,050

$1,051 nationally

Weight-loss brands

30%

13th highest share of 51

Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 30% of Tennessee Medicaid's GLP-1 prescriptions in 2025 (40,724). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea.

Tennessee Medicaid GLP-1 prescriptions by brand, 2025
Brand	Prescriptions	Share	Medicaid paid
Ozempic	58,150	43%	$56.0 million
Mounjaro	30,540	22%	$31.7 million
Wegovyapproved for weight management	26,236	19%	$34.3 million
Zepboundapproved for weight management	14,030	10%	$14.8 million
Trulicity	2,481	1.8%	$2.3 million
Rybelsus	1,943	1.4%	$1.9 million

Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.

On Medicare in Tennessee?

Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.

medicare.gov, read Oct 3, 2026: “You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”

Check the Bridge rules Does Medicare cover GLP-1s?

Tennessee and the states around it

Medicaid’s weight-loss answer (January 2026, KFF) and the partner programs that ship there, priced the same way as above.

State	Medicaid, weight loss	Ship there	Cheapest that ships there
Tennessee	Covered	16	$69/mo
Alabama	Not covered	14	$69/moSnagRx
Arkansas	Not covered	13	$69/moSnagRx
Georgia	Not covered	16	$69/moSnagRx
Kentucky	Not covered	16	$69/moSnagRx
Mississippi	Covered	13	$69/moSnagRx
Missouri	Covered	16	$69/moSnagRx
North Carolina	Covered	17	$69/moSnagRx
Virginia	Covered	17	$69/moSnagRx

All 50 states and DC

GLP-1s in Tennessee: common questions

Does Tennessee Medicaid cover Wegovy or Zepbound for weight loss?

It did as of January 2026: KFF lists Tennessee Medicaid among the 13 state programs covering GLP-1s for obesity under fee-for-service. When covered, GLP-1s typically need prior authorization. Coverage can differ in a managed care plan, so ask your plan before you fill.

Does Tennessee Medicaid cover Ozempic or Mounjaro for diabetes?

Yes. Weight-loss coverage is optional for states, but Medicaid must cover GLP-1s approved for type 2 diabetes, so Ozempic, Mounjaro and the others are covered for blood sugar in Tennessee as in every state, usually behind prior authorization. Wegovy for heart risk and Zepbound for sleep apnea are required uses too (KFF).

Has Tennessee Medicaid joined the BALANCE model?

We could not find a published list of the state Medicaid programs taking part, so we cannot say. BALANCE is a voluntary CMS model: states could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026 (KFF). It does not change what you pay, because federal law already limits Medicaid out-of-pocket costs to nominal amounts. Ask Tennessee Medicaid whether it joined.

What is the cheapest GLP-1 program that ships to Tennessee?

SnagRx, at $69 a month, month to month all in (membership included), checked Oct 8, 2026. Then Embody at $69 on a 12-month plan, and CoreAge Rx at $99, month to month. These are telehealth programs: a clinician licensed in Tennessee reviews you online and a pharmacy mails the medication.

How many GLP-1 telehealth programs ship to Tennessee?

16 of the 21 partner programs we track ship to Tennessee on a state list we could verify. 1 name Tennessee as a state they do not serve: Enhance MD. 4 publish a state count without the list, so we cannot say: bmiMD, DudeMeds, TMates, SkinnyRx.

How many GLP-1 prescriptions did Tennessee Medicaid pay for in 2025?

135,961, 20th of the 50 states and DC, with $142.7 million reimbursed before rebates (CMS State Drug Utilization Data). Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 30% of those prescriptions.

Can I get a GLP-1 for $50 a month on Medicare in Tennessee?

If you have Medicare Part D and meet the rules, yes. Medicare's temporary GLP-1 Bridge is the same in every state: medicare.gov says "This temporary program is available nationwide (including all states and U.S. territories) to certain people with Medicare drug coverage (Part D)" and "You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug)." (read Oct 3, 2026).

Sources

Program prices are read off each seller’s own page weekly; the last check behind this page was Oct 3, 2026. The Medicaid answer is KFF’s, quoted below with the day we read it, and is re-read monthly. The prescription figures are CMS’s.

KFF state map, the Tennessee row

“Tennessee,TN,Coverage in place and covers GLP-1s for obesity treatment”

https://datawrapper.dwcdn.net/GL0OB/8/dataset.csv · read Oct 8, 2026

KFF, published Jan 16, 2026

“13 state Medicaid programs covering GLP-1s for obesity treatment under FFS as of January 2026”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Oct 8, 2026

KFF, what Medicaid must cover

“coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Oct 8, 2026

KFF, required uses besides diabetes

“for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound)”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Oct 8, 2026

KFF, prior authorization

“When covered, GLP-1s are typically subject to utilization controls such as prior authorization, which can further limit access.”

https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/ · read Oct 8, 2026

KFF on BALANCE, state rollout

“For state Medicaid agencies that opt to participate in the model, implementation will be on a rolling basis from May 1, 2026 through January 1, 2027.”

https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ · read Oct 8, 2026

KFF on BALANCE, deadlines

“The date for manufacturers to notify CMS of their interest in participating was January 8, 2026; for Medicare Part D plans was April 20, 2026; and for state Medicaid programs is July 31, 2026”

https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ · read Oct 8, 2026

KFF on BALANCE, what you pay

“The model will not affect out-of-pocket costs for Medicaid enrollees, which are limited to nominal amounts under federal law.”

https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ · read Oct 8, 2026

Medicare, the GLP-1 Bridge

“This temporary program is available nationwide (including all states and U.S. territories) to certain people with Medicare drug coverage (Part D)”

https://www.medicare.gov/coverage/weight-loss-drugs · read Oct 3, 2026

Medicare, the Bridge copay

“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”

https://www.medicare.gov/coverage/weight-loss-drugs · read Oct 3, 2026

CMS dataset

State Drug Utilization Data 2025, CMS State Drug Utilization Data, data.medicaid.gov

https://data.medicaid.gov/dataset/158a1baa-5506-400a-8ec3-97756f0b0536 · updated by CMS Jul 13, 2026

Full brief: KFF, Medicaid Coverage of and Spending on GLP-1s. Not insurance or medical advice: your plan and your prescriber decide.

$69/mo is Tennessee's floor today. It moves.

One email when a program that ships to Tennessee gets cheaper.

Every state